Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000202758 | SCV000257660 | uncertain significance | not specified | 2015-04-12 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001185802 | SCV001352106 | uncertain significance | Cardiomyopathy | 2023-06-28 | criteria provided, single submitter | clinical testing | This missense variant replaces alanine with threonine at codon 1639 of the MYH7 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with MYH7-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV001508721 | SCV001715062 | uncertain significance | not provided | 2020-03-26 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001508721 | SCV003817684 | uncertain significance | not provided | 2023-09-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV003586168 | SCV004270917 | uncertain significance | Hypertrophic cardiomyopathy | 2023-08-10 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 1639 of the MYH7 protein (p.Ala1639Thr). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYH7 protein function. ClinVar contains an entry for this variant (Variation ID: 218434). This missense change has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 30297972). This variant is not present in population databases (gnomAD no frequency). |